PSIP1 and ovarian carcinoma: Although our previous pan-cancer expression study did not detect significant LEDGF/p75 overexpression in ovarian cancer [44], it would be of interest to determine if this protein is upregulated in a subset of ovarian tumors contributing to resistance to the DNA damage-inducing chemotherapeutic drugs cisplatin, carboplatin, and Olaparib.